Ligand validation:3NUV

ASD: 4-ANDROSTENE-3-17-DIONE

ASD is a Ligand Of Interest in 3NUV designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3NUV_ASD_B_126	50%	16%	0.121	0.879	1.59	2.09	4	11	4	0	95%	0.9524
3NUV_ASD_A_126	36%	28%	0.187	0.88	1.35	1.51	2	5	0	0	100%	0.5
3NBR_ASD_A_129	4%	15%	0.266	0.627	1.83	1.96	4	9	0	0	100%	0.5
3NHX_ASD_A_126	0%	8%	0.635	0.704	1.83	2.8	7	13	2	0	100%	0.5
4JBT_ASD_B_502	87%	39%	0.068	0.94	0.83	1.52	1	7	0	0	100%	1
4QDC_ASD_A_404	85%	31%	0.101	0.965	1.06	1.67	1	9	0	0	100%	1
8JBZ_ASD_AAA_602	82%	60%	0.104	0.958	0.56	0.98	-	2	5	0	100%	1
4QCK_ASD_A_404	81%	45%	0.124	0.978	0.83	1.27	1	4	0	0	100%	1
6UCY_ASD_B_201	67%	82%	0.135	0.943	0.28	0.52	-	-	0	0	100%	0.64

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.